Drug · DIN 02496755
REGIOCIT
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since May 6, 2024; first marketed July 27, 2020.
- Drug Identification Number (DIN)
- 02496755
- Company (DIN owner)
- Vantive UlcMississauga, Ontario, Canada
- Schedule
- Ethical
- Dosage form
- Solution
- Route
- Extracorporeal
- Therapeutic class (ATC)
- Hemofiltrates B05ZB
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SODIUM CHLORIDE | 5.03 G | L |
| SODIUM CITRATE | 5.29 G | L |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 17, 2024: NOC 33076New Drug Submission (NDS) · Administrative: Change in Product Ownership
- March 3, 2020: NOC 23292New Drug Submission (NDS)